Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Lazlo Pierce who wrote (9792)	6/9/1998 4:05:00 PM
From: Rajiv	Read Replies (2) \| Respond to of 18691

Briefing.com's writeup on CCSI CHROMATICS COLOR SCIENCES (CCSI) 6 1/2 -2 5/16. Professional short-sellers are a vicious bunch: they grab, hold, kick, and bite in an attempt to frighten longs out of their positions. When working the media, they suggest to reporters that a company is cooking the books. Online, the typical scare tactic is a rumor that the CEO is being investigated by the SEC. In the trading pits, the earnings warning is the rumor of choice. Then, there is Manuel Asensio, the head of professional short-selling outfit Asensio & Company, Inc. When he comes after a company, there is no mincing of words. There is no insinuation that the company is dealing under the table. No, Mr. Asensio will flat out call a company's executives crooked. In this particular case he goes two steps further, calling CCSI a worthless stock that has been manipulated in a collusive way among CCSI owners, its advisers and, most recently, at two Dreyfus mutual funds that invested "unconscionable amounts in CCSI stock that has contributed to huge losses in the funds." (Told you, the guy doesn't mince words). His initiation of the stock with both a "strong sell" and "strong short" rating has dragged CCSI shares down 25% today on 15 times average daily volume. CCSI shares have spiraled 50% lower over the past week. The Asenio report claims that not only have CCSI and related parties manipulated the stock, but that the company's only product has no sales or licensing potential. According to Asenio, Colormate III, a color measurement system claimed to detect jaundice in infants, is actually over 10 years old and that the product has not logged a sale since winning FDA marketing approval almost a year ago. (Chromatics Color notes that it is currently engaged in late stage negotiations with potential manufacturing and distribution partners). We must admit that we are not that familiar with CCSI. As far as Mr. Asenio is concerned, we know that his research has made investors heady returns in the past. But even if he turns out to be correct about this company, there is still no guarantee that investors will not get caught in a short-squeeze instigated by professional daytraders who care absolutely nothing about the company's fundamentals, just that the stock is heavily shorted and could fly under the right conditions.